Controversies 2023 Program Evaluation

 

1

2

3

4

5

• Thank you for taking the time to complete this CME evaluation. Your feedback is very important to the program directors.
  
  You will receive your certificate as a PDF attachment via email within two (2) weeks of submission. The subject line will be "Controversies 2023 CME Certificate".

• Name and degrees/credentials(Required)

  Please enter your name exactly as you would like it to appear on your certificate, including degrees and/or credentials.

  Your evaluation answers will be kept strictly confidential.

  Name and degrees/credentials
• Email Address(Required)
  Please note that you will receive your certificate as a PDF attachment via email from Promedica International within two (2) weeks of submission. The subject line will be "Controversies 2023 CME Certificate".
  Enter Email Confirm Email
• Type of Certificate(Required)
  • AMA PRA Category 1 Credits
  • Nursing CE Contact Hours
  • Perfusion CEUs (approved by the ABCP)
  • No Credit Needed (No certificate will be sent if this is chosen)

• ---

  
  Please Note:The reporting deadlines for ABIM MOC Points and CME Passport have passed. If you need credits reported, please email Rebecca Law and we will contact the organizations to find out if late reporting is currently allowed.
• Promedica International is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Promedica International designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• Provider approved by the California Board of Registered Nursing, Provider #8495 for 14.5 Contact Hours.
• The American Board of Cardiovascular Perfusion (ABCP) will allot a total of 17.60 Category 1 CEUs for perfusionists for Thursday, November 30 (9.60), and Friday, December 1 (8.0).
• Number of AMA PRA Category 1 Credit(s)™(Required)
  Please enter a number from 1 to 14.5.
• Hidden
  Would you like to also claim ABIM MOC points for your participation?(Required)

  PLEASE NOTE: Physicians participating in the ABIM's Maintenance of Certification (MOC) program are able to claim MOC Points via this online evaluation form. In order to ensure that the MOC Points will count toward any MOC requirements for 2023, the form must be submitted by December 21, 2023. PMI will be closed over the Holidays, however will continue to report ABIM MOC Points upon return on January 2, 2024. Evaluations received after December 21, 2023 and before March 15, 2024 will continue to be reported to the ABIM and any ABIM Board Certified physician who experienced a negative status change as a direct result of insufficient MOC points will have their status adjusted once the required points have been earned.
  
  If you need the MOC points to count for your 2023 record, please be sure to submit your evaluation by December 21, 2023. MOC points will not be reportable for this course after March 15, 2024.

  • No
  • Yes
• Hidden
  ABIM ID(Required)
  If you do not know your ABIM ID, you can look it up here: https://www.abim.org/verify-physician.aspx.
• 
  PHYSICIANS: With your permission, Promedica International CME will report your CME credit to CME Passport, the ACCME's new centralized web application. If you create a personalized account with CME Passport, you can view, track, and generate transcripts of your reported CME credits. Create a free account with CME Passport at https://www.cmepassport.org/. Non-Physicians, please disregard this section and click "Next" below.
• Hidden
  CME Passport (Physicians Only)
  I give my permission for Promedica International CME to report my CME credit to CME Passport for the 34th Annual Cardiovascular Interventions symposium.
• Hidden
  Date of Birth (Required for both ABIM MOC & CME Passport Reporting)(Required)
  Month

  Day

  Year
• Hidden
  Licensing State(Required)
  AlabamaAlaskaAmerican SamoaArizonaArkansasCaliforniaColoradoConnecticutDelawareDistrict of ColumbiaFloridaGeorgiaGuamHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaNorthern Mariana IslandsOhioOklahomaOregonPennsylvaniaPuerto RicoRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahU.S. Virgin IslandsVermontVirginiaWashingtonWest VirginiaWisconsinWyomingArmed Forces AmericasArmed Forces EuropeArmed Forces Pacific State
• Hidden
  Medical License Number(Required)
• Number of Contact Hours(Required)
  Please enter a number from 1 to 14.5.
• Nursing License Number(Required)
• Number of CEUs(Required)
  Please enter a number from 1 to 17.60.

• Overall comments on the symposium
• Please share what you have learned and will change or maintain in your practice and/or patient care as a result of this symposium. **This reflective statement is required in order to claim ABIM MOC Points**
• Did you hear anything in the accredited presentations that favored a specific product or company, not backed by clinical data?(Required)
  **If the answer is yes, it is important that you note the lecture/speaker and product concerned in the space provided.
  • No
  • Yes
• Comment(Required)

• ---

• Educational Objectives

  Please rate how well you feel each educational objective was addressed.

  After attending the symposium, participants should be able to:

• Analyze the latest advancements and emerging treatments for atherosclerosis and dyslipidemia

  Excellent	Very Good	Good	Fair	Poor

• Evaluate the future of artificial intelligence in cardiovascular medicine and healthcare

  Excellent	Very Good	Good	Fair	Poor

• Discuss updates in the treatment of structural heart disease, including TAVR, mitral regurgitation, and percutaneous tricuspid valve repair

  Excellent	Very Good	Good	Fair	Poor

• Identify the patients who will benefit from renal denervation, and assess the role of novel emerging medications in hypertension management

  Excellent	Very Good	Good	Fair	Poor

• Evaluate the latest debates and controversies in clinical electrophysiology

  Excellent	Very Good	Good	Fair	Poor

• Describe recent updates and the roles of cardiac imaging, including coronary CT, cardiac PET and SPECT MPI, cardiac MRI, and multimodality imaging

  Excellent	Very Good	Good	Fair	Poor

• Examine myosin inhibitors vs. septal reduction therapy in the treatment of hypertrophic cardiomyopathy

  Excellent	Very Good	Good	Fair	Poor

• Discuss expert views on coronary artery disease, including the heart team, left main intervention, and optimal PCI

  Excellent	Very Good	Good	Fair	Poor

• Understand and discuss recent changes in understanding ischemic heart disease

  Excellent	Very Good	Good	Fair	Poor

• Overall Program Review

• Program Review: November 30 - December 1(Required)

  	Excellent	Very Good	Good	Fair	Poor	*Did not attend session
  Atherosclerosis and Dyslipidemia
  Structural Heart Disease
  AI in CV Medicine
  Practice Changing Trials 2023
  Hypertentsion
  Clinical Electrophysiology
  Update in Cardiac Imaging
  Advanced Heart Failure
  Controversies in CAD
  Changes in Ischemic Heart Disease

• Comments on Topics & Speakers
  Please let the Program Directors know what you liked in the 2023 sessions and what you would suggest for future meetings (topics and speakers).

• Needs Assessment

• Your Specialty
  You may select more than one option if applicable.
  • Cardiology, Clinical
  • Cardiology, Interventional
  • Cardiothoracic Surgery
  • Nursing
  • Perfusion
  • Vascular Medicine
  • Other Specialty
• Information about "other"
• Methods of Learning
  You may select more than one option if applicable.
  • Articles
  • DVDs
  • Labs
  • Lectures
  • Webcasting
  • Workshops
  • Other Methods
• Information about "other"
• Barriers to Change
  You may select more than one option if applicable.
  • None
  • Funding/Equipment
  • Hospital/Practice Support
  • Patient Compliance
  • Other Barriers
• Comments
  This field is for validation purposes and should be left unchanged.